Tibet Cheezheng Tibetan Medicine Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Tibet Cheezheng Tibetan Medicine Co., Ltd. carries a market capitalization of 11.53B, placing it among publicly traded companies globally. Its enterprise value stands at 10.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 11.53B |
| Enterprise Value | 10.39B |
Share Statistics
Tibet Cheezheng Tibetan Medicine Co., Ltd. currently has 531.24M shares outstanding.
| Shares Outstanding | 531.24M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Tibet Cheezheng Tibetan Medicine Co., Ltd. trades at a trailing price-to-earnings ratio of 19.32. The price-to-sales ratio is 4.75, and the price-to-book ratio stands at 4.02.
| PE Ratio | 19.32 |
| PS Ratio | 4.75 |
| PB Ratio | 4.02 |
| P/TBV Ratio | 3.15 |
| P/FCF Ratio | 93.27 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Tibet Cheezheng Tibetan Medicine Co., Ltd. trades at an EV/EBITDA multiple of 15.29 and an EV/FCF ratio of 58.19. The EV/Sales ratio of 4.15 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.29 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.15 |
| EV / EBITDA | 15.29 |
| EV / EBIT | 15.29 |
| EV / FCF | 58.19 |
Financial Position
Tibet Cheezheng Tibetan Medicine Co., Ltd. maintains a current ratio of 2.53, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 40.68, indicating elevated leverage, while an interest coverage ratio of 11.93 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.53 |
| Quick Ratio | 1.91 |
| Debt / Equity | 40.68 |
| Debt / EBITDA | 2.45 |
| Interest Coverage | 11.93 |
Financial Efficiency
Tibet Cheezheng Tibetan Medicine Co., Ltd. posts a return on equity of 21.73 and a return on invested capital of 10.52.
| Return on Equity (ROE) | 21.73 |
| Return on Assets (ROA) | 9.06 |
| Return on Invested Capital (ROIC) | 10.52 |
| Return on Capital Employed (ROCE) | 14.38 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.40 |
Taxes
Over the trailing twelve months, Tibet Cheezheng Tibetan Medicine Co., Ltd. has paid 69.92M in income taxes, reflecting an effective tax rate of 10.23.
| Income Tax | 69.92M |
| Effective Tax Rate | 10.23 |
Stock Price Statistics
Tibet Cheezheng Tibetan Medicine Co., Ltd.'s stock has declined approximately -10.88014% over the past 52 weeks. The 50-day moving average sits at 21.15, while the 200-day moving average is 23.72.
| Beta (5Y) | N/A |
| 52-Week Price Change | -10.88014% |
| 50-Day Moving Average | 21.15 |
| 200-Day Moving Average | 23.72 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Tibet Cheezheng Tibetan Medicine Co., Ltd. generated 2.50B in revenue and converted that into 614.99M in net income, yielding earnings per share of 1.16. EBITDA reached 679.13M, while operating income came in at 679.13M.
| Revenue | 2.50B |
| Gross Profit | 2.06B |
| Operating Income | 679.13M |
| Pretax Income | 683.66M |
| Net Income | 614.99M |
| EBITDA | 679.13M |
| EBIT | 679.13M |
| Earnings Per Share (EPS) | 1.16 |
Balance Sheet
Tibet Cheezheng Tibetan Medicine Co., Ltd. holds 3.21B in cash and equivalents against 1.66B in total debt, resulting in a net debt position of 1.31B. Total book value stands at 2.96B, with working capital of 2.57B providing operational flexibility.
| Cash & Cash Equivalents | 3.21B |
| Total Debt | 1.66B |
| Net Debt | 1.31B |
| Equity (Book Value) | 2.96B |
| Book Value Per Share | 5.56 |
| Working Capital | 2.57B |
Cash Flow
After subtracting -127.37M in capital expenditures, free cash flow totaled -127.37M - equivalent to -0.24 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -127.37M |
| Free Cash Flow | -127.37M |
| FCF Per Share | -0.24 |
Margins
Tibet Cheezheng Tibetan Medicine Co., Ltd. operates with a gross margin of 82.23, reflecting its pricing power and cost economics. The operating margin of 27.13 and net profit margin of 24.57 provide insight into operational efficiency.
| Gross Margin | 82.23 |
| Operating Margin | 27.13 |
| Pretax Margin | 27.31 |
| Profit Margin | 24.57 |
| EBITDA Margin | 27.13 |
Dividends & Yields
The company's payout ratio of 64.46 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.74 |
| Dividend Yield | N/A |
| Payout Ratio | 64.46 |
| Shareholder Yield | 5.65 |
| FCF Yield | 1.07 |
Stock Splits
Tibet Cheezheng Tibetan Medicine Co., Ltd.'s most recent stock split took place on July 11, 2019 with a 500000:649167 split ratio.
| Last Split Date | 7/11/2019 |
| Split Ratio | 500000:649167 |
Scores
Tibet Cheezheng Tibetan Medicine Co., Ltd. posts an Altman Z-Score of 4.32, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.32 |